Viridian Therapeutics, Inc./DE Class of Warrant or Right, Outstanding
Viridian Therapeutics, Inc./DE (VRDN) had Class of Warrant or Right, Outstanding of 29.45 thousand shares as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-02-26
- 2025-12-31: Class of Warrant or Right, Outstanding 29.45K shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 29.45K shares.
- 2025-06-30: Class of Warrant or Right, Outstanding 29.45K shares.
- 2025-03-31: Class of Warrant or Right, Outstanding 30.23K shares.
| Period end | Class of Warrant or Right, Outstanding | Class of Warrant or Right, Outstanding as first filed |
|---|---|---|
| 2025-12-31 | 29.45K shares 10-K · filed 2026-02-26 | |
| 2025-09-30 | 29.45K shares 10-Q · filed 2025-11-05 | |
| 2025-06-30 | 29.45K shares 10-Q · filed 2025-08-06 | |
| 2025-03-31 | 30.23K shares 10-Q · filed 2025-05-06 | |
| 2024-12-31 | 248.28K shares 10-K · filed 2026-02-26 | |
| 2024-09-30 | 249.88K shares 10-Q · filed 2024-11-12 | |
| 2024-06-30 | 249.88K shares 10-Q · filed 2024-08-08 | |
| 2024-03-31 | 249.88K shares 10-Q · filed 2024-05-08 | |
| 2023-12-31 | 249.88K shares 10-K · filed 2025-03-03 | |
| 2023-09-30 | 249.88K shares 10-Q · filed 2023-11-13 | |
| 2023-06-30 | 249.88K shares 10-Q · filed 2023-08-08 | |
| 2023-03-31 | 306.55K shares 10-Q · filed 2023-05-10 | |
| 2022-12-31 | 363.96K shares 10-K · filed 2024-02-27 | |
| 2022-09-30 | 363.96K shares 10-Q · filed 2022-11-14 | |
| 2021-12-31 | 420.63K shares 10-K · filed 2023-03-09 | |
| 2021-09-30 | 441.55K shares 10-Q · filed 2021-11-05 | |
| 2021-06-30 | 441.55K shares 10-Q · filed 2021-08-12 | |
| 2021-03-31 | 441.55K shares 10-Q · filed 2021-05-07 | |
| 2020-12-31 | 498.50K shares 10-K · filed 2022-03-11 | |
| 2020-09-30 | 7.54M shares 10-Q · filed 2020-11-12 | |
| 2020-06-30 | 7.54M shares 10-Q · filed 2020-08-05 | |
| 2020-03-31 | 7.54M shares 10-Q · filed 2020-05-08 | |
| 2019-12-31 | 3.10K shares 10-K · filed 2021-03-26 | 46.52K shares 10-Q · filed 2020-05-08 |
| 2016-12-31 | 13.53K shares 10-K · filed 2017-03-24 | |
| 2016-09-30 | 203.21K shares 10-Q · filed 2016-10-26 | |
| 2016-06-30 | 203.21K shares 10-Q · filed 2016-08-15 | |
| 2016-03-31 | 203.21K shares 10-Q · filed 2016-05-16 | |
| 2015-12-31 | 203.21K shares 10-K · filed 2016-03-21 | |
| 2015-09-30 | 203.21K shares 10-Q · filed 2015-11-13 | |
| 2015-06-30 | 203.21K shares 10-Q · filed 2015-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |